Possible Roles of MDW in Infection Management in Emergency Care

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04448548

Enrollment

300

Registered

2020-06-26

Start date

2019-09-01

Completion date

2020-01-31

Last updated

2020-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Sepsis

Brief summary

A retrospective study to determine the potential value of MDW among other biomarkers in the diagnosis of infection.

Detailed description

MDW as a novel indicator can be useful in clinical practice in the emergency care. However, until now, no study has been published about MDW's general relationship and coherence with multiple, conventional laboratory tests for infections, such as PCT, C-reactive protein (CRP), WBC, neutrophil count (NC), neutrophil percentage and immature granulocyte count (IGC) together.

Interventions

OTHERblood sample taking

For study purposes, blood sample was taken during the first medical examination from patients with suspected infection.

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* adult (18+ years), receiving care for suspected infection

Exclusion criteria

* refuses to sign the consent form

Design outcomes

Primary

Measure	Time frame	Description
MDW cutoff value for infection	4 months	Cutoff value for MDW indicating infection

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026